Co-investment & Grants
We invest in innovative technologies.
We are a unique commercialisation fund helping researchers from our partner research organisations turn their ideas into products and services. We support innovations that solve market problems and create a positive impact for our community. Uniseed invests over a broad range of technology sectors and has exited twelve investments, to date.
How we help
Seed capital investment
We invest in your innovation to help you progress and de-risk from both a technical and commercial perspective.
We believe in supporting your progress through collaboration and mentoring.
You will have the ability to access Uniseed’s network of industry experts, co-investors and start-up experts.
We help you build your strategy, manage your intellectual property and identify commercial partners.
Rewards & recognition
Boost career profile, publications, conferences, patent publications and increase your visibility.
Make an impact
Impact our community by solving market problems through your innovation.
Our Process ›
Step 1: Make Contact
Get in contact through your commercialisation office or directly with us. Initial meetings and discussions will start with an Investment Manager. Tell us about your innovative opportunity and we will assist in identifying the most appropriate pathway forward.
Step 2: Pitch to Us
Promising eligible opportunities will have the opportunity to pitch to the Uniseed Investment Committees (which convenes monthly) and receive feedback.
Step 3: Due Diligence & Negotiation
Uniseed conducts detailed due diligence on your opportunity which may include further presentation(s) to our investment committee. We syndicate promising deals with your co-investors (as required)
Step 4: Investment & Growth
Investment capital is provided. Uniseed provides expert guidance and access to networks. We also help to develop, grow and scale your innovation.
Step 5: Impact & Exit
Generate impact through your innovation. Receive awards and recognition. Exit and achieve a return for shareholders.
Certa Therapeutics’ investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases
Research presented today by University of Michigan Medical School highlights FT011’s ground-breaking treatment potential from human expression profiles in chronic kidney disease study supported by animal model data The research demonstrated that...
Uniseed invests in Tiny Bright Things (TBT), a light microscopy technology to image and measure at any scale
Melbourne, 3 November 2022 – Uniseed has led a $1.5M investment round in the Australian microscopy products company Tiny Bright Things (TBT) to transform the way researchers and manufacturers see and measure tiny or transparent objects....
Uniseed invests in University of Queensland Quantum Computing Technology company, Analog Quantum Circuits.
Brisbane, 11 October 2022 - Uniseed has committed $3M to an investment in Australian quantum technology company Analog Quantum Circuits (AQC) to fund the development of key components required for the scale up of quantum...